Sonia D'inzeo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data.

Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data.

Journal: PeerJ

Published: August 29, 2019

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.

Journal: PeerJ

Published: December 07, 2018

Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.

Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.

Journal: Cancer medicine

Published: August 31, 2017

The role of peroxiredoxins in cancer.

The role of peroxiredoxins in cancer.

Journal: Molecular and clinical oncology

Published: July 01, 2016

Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.

Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.

Journal: Clinical biochemistry

Published: January 08, 2015

Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.

Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.

Journal: Breast cancer research and treatment

Published: July 30, 2014

Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes.

Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes.

Journal: The international journal of biochemistry & cell biology

Published: November 13, 2013

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.

Journal: International journal of oncology

Published: September 18, 2013

Effects of the Smad4 C324Y mutation on thyroid cell proliferation.

Effects of the Smad4 C324Y mutation on thyroid cell proliferation.

Journal: International journal of oncology

Published: January 16, 2013

[Corrigendum] The p85α regulatory subunit of PI3K mediates cAMP‑PKA and retinoic acid biological effects on MCF7 cell growth and migration.

[Corrigendum] The p85α regulatory subunit of PI3K mediates cAMP‑PKA and retinoic acid biological effects on MCF7 cell growth and migration.

Journal: International journal of oncology

Published: November 29, 2011

A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression.

A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression.

Journal: Endocrine-related cancer

Published: November 24, 2011

The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration.

The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration.

Journal: International journal of oncology

Published: October 13, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026